PD-1 and PD-L1 Inhibitors
33 places
Worldwide report
Every place
- 33Reports naming them
- 1Markets they lead in
- 33Regions & countries
- 68Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Innovent Biologics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Where they show up
33 reportsOur reports that name Innovent Biologics as a key player, by category and place.
- Pharmaceuticals · 33
Places 33
- Africa 1
- APAC 1
- Australia 1
- Brazil 1
- Canada 1
- China 1
- Ecuador 1
- Egypt 1
- Europe 1
France 1- Germany 1
- Global 1
Hong Kong 1
India 1
Italy 1
Japan 1
Kenya 1- Latin America 1
Malaysia 1
Mexico 1- Middle East 1
New Zealand 1- North America 1
Philippines 1
Russia 1
Saudi Arabia 1
Singapore 1
South Africa 1
Spain 1
Thailand 1- UAE 1
UK 1
US 1
Innovent Biologics's markets
1Markets where they are a key player. Each opens the market's statistics for every place we cover.
Pharmaceuticals1
None of their markets match.
Recent reports naming Innovent Biologics
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
33 places
Companies they compete with most
Named as key players in the same markets as Innovent Biologics (number of shared markets).
AstraZeneca1 shared market
BeiGene1 shared market
Bristol-Myers Squibb1 shared market
Merck & Co., Inc.1 shared market
Roche1 shared market
Free public data on Innovent Biologics
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- innoventbio.com
- Home country
- China
- Stock listing
- HKEX: 1801
- Legal name
- Innovent Biologics, Inc.
Clinical trials
68 active studies led by Innovent Biologics, of 206 in all
Source: ClinicalTrials.gov, Studies with Innovent Biologics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Trials over time
Studies Innovent Biologics leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Innovent Biologics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Also active in
Markets we cover where free public records show Innovent Biologics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Innovent Biologics is in.
From our blog
Stories on the topics Innovent Biologics works in.
Weight Management Supplements in the GLP-1 Era
2.6 billion adults are overweight. GLP-1 medicines are changing weight care, while most supplements lack…
Read
Collagen Supplements: Skin, Joints and Real Evidence
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read